Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to ANGPTL3 mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridaemia
D. Gaudet, E. Karwatowska-Prokopczuk, S. Baum, E. Hurh +9 more
2020European Heart Journal248 citations Open access
Semantic Scholar

